Cite
Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials.
MLA
Staffaroni, Adam M., et al. “Longitudinal Multimodal Imaging and Clinical Endpoints for Frontotemporal Dementia Clinical Trials.” Brain: A Journal of Neurology, vol. 142, no. 2, Feb. 2019, pp. 443–59. EBSCOhost, https://doi.org/10.1093/brain/awy319.
APA
Staffaroni, A. M., Ljubenkov, P. A., Kornak, J., Cobigo, Y., Datta, S., Marx, G., Walters, S. M., Chiang, K., Olney, N., Elahi, F. M., Knopman, D. S., Dickerson, B. C., Boeve, B. F., Gorno-Tempini, M. L., Spina, S., Grinberg, L. T., Seeley, W. W., Miller, B. L., Kramer, J. H., & Boxer, A. L. (2019). Longitudinal multimodal imaging and clinical endpoints for frontotemporal dementia clinical trials. Brain: A Journal of Neurology, 142(2), 443–459. https://doi.org/10.1093/brain/awy319
Chicago
Staffaroni, Adam M, Peter A Ljubenkov, John Kornak, Yann Cobigo, Samir Datta, Gabe Marx, Samantha M Walters, et al. 2019. “Longitudinal Multimodal Imaging and Clinical Endpoints for Frontotemporal Dementia Clinical Trials.” Brain: A Journal of Neurology 142 (2): 443–59. doi:10.1093/brain/awy319.